Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Dec 8;82(1):241–245. doi: 10.1054/bjoc.1999.0906

Height-related risk factors for prostate cancer

A E Norrish 1, C U McRae 2, I M Holdaway 3, R T Jackson 1
PMCID: PMC2363202  PMID: 10638996

Abstract

Previous studies have reported that adult height is positively associated with the risk of prostate cancer. The authors carried out a population-based case–control study involving 317 prostate cancer cases and 480 controls to further investigate the possibility that height is more strongly associated with advanced, compared with localized forms of this disease. Since the inherited endocrine factors, which in part determine height attained during the growing years, may influence the risk of familial prostate cancer later in life, the relationship with height was also investigated for familial versus sporadic prostate cancers. Adult height was not related to the risk of localized prostate cancer, but there was a moderate positive association between increasing height and the risk of advanced cancer (relative risk (RR) = 1.62; 95% confidence interval (CI) 0.97–2.73, upper versus lowest quartile, P -trend = 0.07). Height was more strongly associated with the risk of prostate cancer in men with a positive family history compared with those reporting a negative family history. The RR of advanced prostate cancer for men in the upper height quartile with a positive family history was 7.41 (95% CI 1.68–32.67, P -trend = 0.02) compared with a reference group comprised of men in the shortest height quartile with a negative family history. Serum insulin-like growth factor-1 levels did not correlate with height amongst men with familial or sporadic prostate cancers. These findings provide evidence for the existence of growth-related risk factors for prostate cancer, particularly for advanced and familial forms of this disease. The possible existence of inherited mechanisms affecting both somatic and tumour growth deserves further investigation. © 2000 Cancer Research Campaign

Keywords: prostate neoplasms, height, growth, familial, IGF-1

Full Text

The Full Text of this article is available as a PDF (53.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson S. O., Baron J., Bergström R., Lindgren C., Wolk A., Adami H. O. Lifestyle factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):509–513. [PubMed] [Google Scholar]
  2. Andersson S. O., Wolk A., Bergström R., Adami H. O., Engholm G., Englund A., Nyrén O. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst. 1997 Mar 5;89(5):385–389. doi: 10.1093/jnci/89.5.385. [DOI] [PubMed] [Google Scholar]
  3. Chan J. M., Stampfer M. J., Giovannucci E., Gann P. H., Ma J., Wilkinson P., Hennekens C. H., Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998 Jan 23;279(5350):563–566. doi: 10.1126/science.279.5350.563. [DOI] [PubMed] [Google Scholar]
  4. Cohen P., Peehl D. M., Graves H. C., Rosenfeld R. G. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol. 1994 Sep;142(3):407–415. doi: 10.1677/joe.0.1420407. [DOI] [PubMed] [Google Scholar]
  5. Cohen P., Peehl D. M., Lamson G., Rosenfeld R. G. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab. 1991 Aug;73(2):401–407. doi: 10.1210/jcem-73-2-401. [DOI] [PubMed] [Google Scholar]
  6. Ekbom A., Hsieh C. C., Lipworth L., Wolk A., Pontén J., Adami H. O., Trichopoulos D. Perinatal characteristics in relation to incidence of and mortality from prostate cancer. BMJ. 1996 Aug 10;313(7053):337–341. doi: 10.1136/bmj.313.7053.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gann P. H., Hennekens C. H., Ma J., Longcope C., Stampfer M. J. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst. 1996 Aug 21;88(16):1118–1126. doi: 10.1093/jnci/88.16.1118. [DOI] [PubMed] [Google Scholar]
  8. Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Willett W. C. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):557–563. [PubMed] [Google Scholar]
  9. Gluckman P. D., Johnson-Barrett J. J., Butler J. H., Edgar B. W., Gunn T. R. Studies of insulin-like growth factor -I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol (Oxf) 1983 Sep;19(3):405–413. doi: 10.1111/j.1365-2265.1983.tb00014.x. [DOI] [PubMed] [Google Scholar]
  10. Goodman-Gruen D., Barrett-Connor E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol. 1997 Jun 1;145(11):970–976. doi: 10.1093/oxfordjournals.aje.a009065. [DOI] [PubMed] [Google Scholar]
  11. Hebert P. R., Ajani U., Cook N. R., Lee I. M., Chan K. S., Hennekens C. H. Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control. 1997 Jul;8(4):591–597. doi: 10.1023/a:1018442329319. [DOI] [PubMed] [Google Scholar]
  12. Juul A., Dalgaard P., Blum W. F., Bang P., Hall K., Michaelsen K. F., Müller J., Skakkebaek N. E. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 1995 Aug;80(8):2534–2542. doi: 10.1210/jcem.80.8.7543116. [DOI] [PubMed] [Google Scholar]
  13. Keenan B. S., Richards G. E., Ponder S. W., Dallas J. S., Nagamani M., Smith E. R. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab. 1993 Apr;76(4):996–1001. doi: 10.1210/jcem.76.4.8473416. [DOI] [PubMed] [Google Scholar]
  14. Le Marchand L., Kolonel L. N., Wilkens L. R., Myers B. C., Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology. 1994 May;5(3):276–282. doi: 10.1097/00001648-199405000-00004. [DOI] [PubMed] [Google Scholar]
  15. Mantzoros C. S., Tzonou A., Signorello L. B., Stampfer M., Trichopoulos D., Adami H. O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer. 1997;76(9):1115–1118. doi: 10.1038/bjc.1997.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Millar W. J. Distribution of body weight and height: comparison of estimates based on self-reported and observed measures. J Epidemiol Community Health. 1986 Dec;40(4):319–323. doi: 10.1136/jech.40.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Palta M., Prineas R. J., Berman R., Hannan P. Comparison of self-reported and measured height and weight. Am J Epidemiol. 1982 Feb;115(2):223–230. doi: 10.1093/oxfordjournals.aje.a113294. [DOI] [PubMed] [Google Scholar]
  18. Rajah R., Valentinis B., Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem. 1997 May 2;272(18):12181–12188. doi: 10.1074/jbc.272.18.12181. [DOI] [PubMed] [Google Scholar]
  19. Smith J. R., Freije D., Carpten J. D., Grönberg H., Xu J., Isaacs S. D., Brownstein M. J., Bova G. S., Guo H., Bujnovszky P. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 1996 Nov 22;274(5291):1371–1374. doi: 10.1126/science.274.5291.1371. [DOI] [PubMed] [Google Scholar]
  20. Stewart A. W., Jackson R. T., Ford M. A., Beaglehole R. Underestimation of relative weight by use of self-reported height and weight. Am J Epidemiol. 1987 Jan;125(1):122–126. doi: 10.1093/oxfordjournals.aje.a114494. [DOI] [PubMed] [Google Scholar]
  21. Tibblin G., Eriksson M., Cnattingius S., Ekbom A. High birthweight as a predictor of prostate cancer risk. Epidemiology. 1995 Jul;6(4):423–424. doi: 10.1097/00001648-199507000-00017. [DOI] [PubMed] [Google Scholar]
  22. Xu J., Meyers D., Freije D., Isaacs S., Wiley K., Nusskern D., Ewing C., Wilkens E., Bujnovszky P., Bova G. S. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet. 1998 Oct;20(2):175–179. doi: 10.1038/2477. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES